News for ClearPoint Neuro, Inc. (CLPT)

Published at

Jul 24, 2025 4:17 AM

by gurufocus.com

positive

positive

BlackRock, Inc. Acquires Significant Stake in ClearPoint Neuro Inc

On June 30, 2025, BlackRock, Inc. (Trades, Portfolio) executed a notable transaction by acquiring 1,171,946 shares of ClearPoint Neuro Inc (CLPT) at a trade pri

NVDAD.BA NVDAC.BA NVDA.MI CLPT APC.DE AMZN.SN AMZN.MX AMZ.DE AAPL.NE AAPL.MX

Read more →
Published at

Jul 24, 2025 3:00 AM

by gurufocus.com

neutral

neutral

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / July 23, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabl

CLPT

Read more →
Published at

Jun 27, 2025 11:46 PM

by seekingalpha.com

positive

positive

ClearPoint Neuro: Consumables Growth Is Promising (NASDAQ:CLPT)

ClearPoint shows strong fundamentals with growth potential from partner programs and treatment revenues in Huntington's and Parkinson's. See more on CLPT.

CLPT

Read more →
Published at

Jun 4, 2025 8:14 PM

by gurufocus.com

positive

positive

ClearPoint Neuro Inc (CLPT) Shares Up 5.25% on Jun 4

Shares of ClearPoint Neuro Inc (CLPT) surged 5.25% in mid-day trading on Jun 4. The stock reached an intraday high of $13.44, before settling at $13.33, up

CLPT

Read more →
Published at

Jun 3, 2025 4:15 PM

by gurufocus.com

positive

positive

ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnership | CLPT Stock News

ClearPoint Neuro (CLPT) is poised to benefit from a significant partnership as uniQure's (QURE) gene therapy, AMT-130, aimed at treating Huntington's disease, m

CLPT

Read more →
Published at

May 14, 2025 9:16 AM

by gurufocus.com

positive

positive

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

Total Revenue: $8.5 million for Q1 2025, up 11% from $7.6 million in Q1 2024.Biologics and Drug Delivery Revenue: Increased 9% to $4.7 million in Q1 2025 from

CLPT

Read more →
Published at

May 14, 2025 7:08 AM

by gurufocus.com

positive

positive

Q1 2025 Clearpoint Neuro Inc Earnings Call Transcript

May 13, 2025 / 08:30PM GMTOperator Greetings, and welcome to ClearPoint Neuro, Inc.'s first-quarter 2025 financial results conference call. (Operator Instructio

CLPT

Read more →
Published at

May 14, 2025 5:57 AM

by gurufocus.com

positive

positive

ClearPoint Neuro (CLPT) Reports Strong Q1 Growth and Strategic Advances

Key Takeaways: ClearPoint Neuro, Inc. (CLPT) reports strong Q1 2025 revenue growth of 11% year-over-year. Analysts forecast an average upside of 94.84%,

CLPT

Read more →
Published at

May 14, 2025 4:02 AM

by seekingalpha.com

positive

positive

ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ETCompany ParticipantsJoseph Burnett - President and Chief...

CLPT

Read more →
Published at

May 14, 2025 3:00 AM

by gurufocus.com

positive

positive

ClearPoint Neuro Reports First Quarter 2025 Results

Record Revenue Highlighted by 70% Growth in Single-Use Navigation and Therapy Products SOLANA BEACH, CALIFORNIA / ACCESS Newswire / May 13, 2025 / ClearPoint Ne

CLPT

Read more →
Published at

May 14, 2025 12:01 AM

by gurufocus.com

positive

positive

ClearPoint Neuro Reports First Quarter 2025 Results | CLPT Stock News

ClearPoint Neuro (CLPT) reported record Q1 2025 revenue of $8.5 million, an 11% increase year-over-year. The company saw a significant 104% growth in co

CLPT

Read more →
Published at

May 13, 2025 11:35 PM

by zacks.com

positive

positive

ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -46.67% and 2.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

CLPT

Read more →
Published at

May 13, 2025 11:01 PM

by seekingalpha.com

neutral

neutral

ClearPoint Neuro reports Q1 results (NASDAQ:CLPT)

ClearPoint Neuro (CLPT) Q1 revenue rises 11.4% YoY to $8.5M, beating estimates. Gross margin improves to 60%.

CLPT

Read more →
Published at

May 13, 2025 3:00 AM

by gurufocus.com

positive

positive

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / May 12, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabli

CLPT

Read more →
Published at

May 12, 2025 11:17 PM

by gurufocus.com

positive

positive

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing | CLPT Stock News

ClearPoint Neuro (CLPT) secures up to $110 million in financing from Oberland Capital. The financing includes a $3.5 million equity purchase and $105 mi

CLPT

Read more →
Published at

Apr 17, 2025 4:30 PM

by benzinga.com

positive

positive

uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday - Avis Budget Gr (NASDAQ:CAR), Capricor Therapeutics (NASDAQ:CAPR)

U.S. stocks were lower, with the Dow Jones index falling around 550 points on Thursday. Shares of uniQure N.V. QURE rose sharply during Thursday's session afte...

ZGY.DE UQ1.DE QURE LLY.MX LLY.DE LLY.BA LLY LILY34.SA IIIN HTZZ HTZGQ HTZ FIS.MX FIS F1NI34.SA EVTCY EVTA.DE EVT.DE EVOTF DT3.DE DLTR.MX DLTR CLPT CAR.MX CAR.BA CAR CAPR 0Q1G.L 0J4Z.L 0ILW.L 0IC8.L 0HK4.L 0EE0.L

Read more →
Published at

Feb 28, 2025 5:18 AM

by seekingalpha.com

positive

positive

ClearPoint Neuro Stock Q4: Drug Delivery Prospects Continue To Strengthen (NASDAQ:CLPT)

ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs driving future prospects. See more here.

CLPT

Read more →
Published at

Feb 27, 2025 8:22 AM

by gurufocus.com

positive

positive

ClearPoint Neuro Inc (CLPT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions

Total Revenue (2024): $31.4 million, a 31% increase from $24 million in 2023.Biologics and Drug Delivery Revenue (2024): $17.3 million, up 27% from $13.6 milli

CLPT

Read more →
Published at

Feb 27, 2025 2:00 AM

by gurufocus.com

positive

positive

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Achieved Record Revenue for 2024 and Growth of 31%;Reduced 2024 Operational Cash Burn by 35% SOLANA BEACH, CALIFORNIA / ACCESS Newswire / February 26, 2025 / Cl

CLPT

Read more →
Published at

Feb 26, 2025 11:30 PM

by zacks.com

negative

negative

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -33.33% and 10.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

CLPT

Read more →